Richard Pulik, CFO at Roivant Sciences Ltd. (ROIV), sold 1,912 shares at $8.08 ($15K) on 2023-03-01, disclosed to the SEC on 2023-03-03.
Scheduled sale ($15k) by CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.